Dongzhi Ran

Key Laboratory Of Biochemistry And Molecular Pharmacology
Chongqing, 400016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

METTL3-m6A-MALAT1 axis exacerbates the autophagy impairment and lipid accumulation in NAFLD by regulating miR-690.

METTL3-m6A-MALAT1 axis exacerbates the autophagy impairment and lipid accumulation in NAFLD by regulating miR-690.

Journal: Biochemical pharmacology

Published: November 10, 2025

miR-690 ameliorates hepatic steatosis by targeting NF-KappaB P65 and regulating 15-LOX to induce autophagy in db/db mice.

miR-690 ameliorates hepatic steatosis by targeting NF-KappaB P65 and regulating 15-LOX to induce autophagy in db/db mice.

Journal: Biochemical pharmacology

Published: January 10, 2025

Concomitant use of low molecular weight heparin mitigates bortezomib-induced peripheral Neuropathy: Analysis of the FDA adverse event reporting system.

Concomitant use of low molecular weight heparin mitigates bortezomib-induced peripheral Neuropathy: Analysis of the FDA adverse event reporting system.

Journal: European journal of pharmacology

Published: January 07, 2025

Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.

Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.

Journal: bioRxiv : the preprint server for biology

Published: May 20, 2024

Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats.

Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats.

Journal: Nature communications

Published: May 07, 2024

A peptidomimetic modulator of the CaV2.2 N-type calcium channel for chronic pain.

A peptidomimetic modulator of the CaV2.2 N-type calcium channel for chronic pain.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 16, 2023

Identification and targeting of a unique NaV1.7 domain driving chronic pain.

Identification and targeting of a unique NaV1.7 domain driving chronic pain.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 27, 2023

Nrf1 Reduces COX-2 Expression and Maintains Cellular Homeostasis After Cerebral Ischemia/Reperfusion By Targeting IL-6/TNF-α Protein Production.

Nrf1 Reduces COX-2 Expression and Maintains Cellular Homeostasis After Cerebral Ischemia/Reperfusion By Targeting IL-6/TNF-α Protein Production.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: February 03, 2023

Neuropilin-1 is essential for vascular endothelial growth factor A-mediated increase of sensory neuron activity and development of pain-like behaviors.

Neuropilin-1 is essential for vascular endothelial growth factor A-mediated increase of sensory neuron activity and development of pain-like behaviors.

Journal: Pain

Published: November 11, 2022

Accurate tumor segmentation and treatment outcome prediction with DeepTOP.

Accurate tumor segmentation and treatment outcome prediction with DeepTOP.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 03, 2022

Cell specific regulation of NaV1.7 activity and trafficking in rat nodose ganglia neurons.

Cell specific regulation of NaV1.7 activity and trafficking in rat nodose ganglia neurons.

Journal: Neurobiology of pain (Cambridge, Mass.)

Published: October 20, 2022

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer.

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: September 13, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026